after the first cycle of vesicle loading/unloading (Morgenthaler, Kraftsik, Catsicas, Magistretti, & Chatton, 2006) , which suggests that sustained synaptic vesicle recycling requires L-lactate or glucose. Under some conditions, L-lactate is a superior energy substrate compared with glucose (Pellerin et al., 2007) . However, the ANLS hypothesis is debatable (Chih & Roberts, 2003; Dienel, 2017; Kimelberg, 2004) .
We aimed to determine whether SDH astrocytes affected mechanical thresholds. To perform a gain-of-function study, we utilized designer receptors exclusively activated by designer drugs (DREADDs) that were selectively expressed in SDH astrocytes. For a loss-of-function study, we pharmacologically manipulated astrocyte function and inhibited L-lactate in the spinal cord. We found that aberrations of the ANLS in the spinal cord were the key feature in the persistent mechanical hyperalgesia and allodynia that characterizes neuropathic pain.
| MATERIALS AND METHODS
All experimental protocols used in this study were approved by the Animal Care and Use Committee of Nagoya City University and performed in accordance with the guidelines of the National Institutes of Health and the Japanese Pharmacological Society.
| Animals
Male ddY mice weighing 20-25 g and C57BL/6 J mice weighing 20 g (virus study) were used. The viral injections of the C57BL/6 J mice were conducted according to a previous protocol (Kohro et al., 2015) .
Five animals were housed in each cage in a room maintained at 23 AE
2
C with an alternating 12-h light-dark cycle. Food and water were available ad libitum. The animals were used only once in all experiments.
| Assessment of mechanical allodynia
The mice were placed in individual transparent Perspex cubicles with a wire mesh bottom, and a series of calibrated von Frey filaments (Semmes-Weinstein monofilaments; Stoelting Co., Wood Dale, IL)
were used to determine the 50% likelihood of a paw withdrawal response (50% threshold) by the up-down method of Dixon (1980) . 
| Western blotting
The spinal cord was removed quickly after the decapitation to measure the levels of protein expression. imaging system (GE Healthcare Japan Co., Ltd., Tokyo, Japan). The intensity of each band was analyzed and semiquantified using computer-assisted densitometry and the NIH imaging system. Each value was normalized by the value for β-actin, which was used as an internal control.
| Immunohistochemistry
The mice were anesthetized with pentobarbital (60 mg/kg, intraperitoneal [i.p.]) and intracardially perfused with phosphate-buffered saline (PBS), which was followed by 4% paraformaldehyde in PBS. The spinal cords were removed and dissected into thick coronal sections.
These tissues were postfixed in the same fixative for 2 hr and then immersed in 30% sucrose/PBS solution overnight. Frozen 8-μm-thick coronal sections were cut with a cryostat (CM1900; Leica Biosystems GmbH, Wetzlar, Germany).
The lumbar spinal cord sections were blocked in 10% normal goat serum in 0.01 M PBS containing 0.4% Triton-X 100 for 2 h at room temperature. The primary antibody was diluted in 0.01 M PBS containing 0.5% bovine serum albumin and 0.4% Triton-X 100 (1:1,000 rabbit polyclonal antibody against c-Fos (Santa Cruz Biotechnology, Inc., Dallas, TX]) and incubated for 2 days at 4 C. The sections were incubated with a secondary antibody conjugated with Alexa 568 (1:2,000) for 2 hr at room temperature. The slides were then mounted under a coverslip with fluorescence mounting medium (Vector Laboratories, Inc., Burlingame, CA). The fluorescence of the immunolabeling was detected using a fluorescence microscope (AxioImager A1; Carl Zeiss AG, Jena, Germany). 
| Intrathecal injections
The 5-μL intrathecal injections were made in unanesthetized mice according to the method of Hylden and Wilcox (1980) 
| SDH microinjections
Although the mice were under pentobarbital anesthesia, the skin was incised at Th12-L3, and the tendon from the Th13-and L1-vertebral columns was resected. The rostral side of the 
| Drugs
The drugs used in this study were L-lactate, α-cyano- 
| Statistical analysis
The data are expressed as the mean AE SEM. Student's t tests were used to evaluate the differences between two groups. The statistical significance of the differences among multiple groups was assessed using multiple t tests and a Bonferroni correction following a one-way analysis of variance (ANOVA). Analyses of the time course experiment were performed using two-way ANOVA. Differences with probability p values < .05 were considered statistically significant.
3 | RESULTS
| SDH astrocyte-specific gene transfer by microinjections of AAV5-gfap
First, we attempted to express genes in the SDH in an astrocytespecific manner using SDH microinjections. We microinjected AAV5 expressing a gene encoding enhanced green fluorescent protein (eGFP) under the control of the gfap promoter (AAV5-gfap-eGFP) unilaterally into the SDH between the Th13 and L1 vertebrae. Four weeks after the AAV injection, GFP fluorescence was expressed exclusively in the SDH ipsilateral, not contralateral, to the injection site ( Figure 1a ). To determine the astrocyte specificity of the transgene expression, we performed immunolabeling using an antibody against the GFAP protein. GFP-expressing cells were labeled with a GFAP antibody (97.7%; n = 4) ( Figure 1b ). In addition, we performed immunolabeling using an antibody against another astrocyte marker protein, S100β. GFP-expressing cells were also labeled with the S100b antibody (99.5%; n = 4) ( Figure 1c ). These results indicated that the intra-SDH microinjections of AAV5-gfap-eGFP induced specific gene expression in L4-SDH astrocytes.
| A critical role of SDH astrocytes in hyperalgesia
To identify the role of the SDH astrocytes in nociceptive perception, we utilized the intraSDH microinjection technique to express a human M3 muscarinic DREADD coupled to Gαq (hM3Dq) in an SDH astrocytespecific manner. DREADDs, which reportedly exhibit no basal activity (Lopez et al., 2016) , are activated by the specific agonist clozapine-Noxide (CNO). We microinjected AAV5 containing a gene encoding Figure S1 ). In contrast, i.p. saline treatment did not affect the L-lactate levels (maximum of 1.4 mM). A two-way ANOVA indicated a significant main effect of time (F 9,54 = 4.04, p < .001) and a significant interaction (F 9,54 = 3.92, p < .001), and a post hoc analysis (Bonferroni test) revealed that DREADD treatment significantly increased the extracellular L-lactate levels relative to saline treatment.
Moreover, the intrathecal administration of 500 ng of 4-CIN, which inhibits the monocarboxylate transporters (MCTs) that deliver L-lactate from astrocytes to neurons, 30 min before CNO administration increased the mechanical threshold in the ipsilateral paw of the SDH microinjection of AAV5-gfap-HA-hM3Dq-IRES-mCitrine (Figure 2b ). An one-way ANOVA analysis indicated significant differences between the groups (F 7,48 = 11.94, p < .0001), and a post hoc analysis (Bonferroni test) revealed a sig- We then examined the effects of a gliotoxin on L-lactate-induced mechanical hyperalgesia. α-AA and fluorocitrate did not affect the Llactate-induced mechanical hyperalgesia (Figure 3d ), which suggested that astrocytes were not involved.
In addition, we examined the effects of isoform-specific MCT knockdown in the L-lactate-induced mechanical hyperalgesia using small interfering RNAs (siRNAs). Each siRNA was injected intrathecally according to a previous protocol (Zhou et al., 2015) , and it downregulated the mRNA expression of each MCT (not significant for MCT4) (Supporting Information Figure S2a L-lactate is converted to pyruvate by lactate dehydrogenase (LDH) after it is taken up by neurons. LDH isoenzyme 5 (LDH5), which is enriched in astrocytes, favors L-lactate production from pyruvate, while LDH1, which is mostly expressed in neurons, preferentially produces pyruvate from L-lactate (Bittar, Charnay, Pellerin, Bouras, & Magistretti, 1996) . A recent study has revealed that isosafrole inhibits LDH1 and LDH5 activity (Sada, Lee, Katsu, Otsuki, & Inoue, 2015) . Figure S4a-d ).
An one-way ANOVA indicated a significant difference between the groups (Arc: F 5,30 = 12.3, p < .001) (Supporting Information Supporting Information Figure S4b ), or (EGR1: F 5,28 = 8.17, p < .001) (Supporting Information Figure S4d ).
| Treatment with L-lactate induced synaptic plasticity-related events in the spinal cord
We tested whether L-lactate treatment influenced the intracellular signaling molecules required for neuropathic pain. The phosphorylation of 3.6 | Effects of inhibiting astrocytes and L-lactate supply on nerve injury-induced neuropathic pain in mice The role of astrocytes in nociceptive transmission remains unknown because of the lack of suitable tools for their specific activation. We used AAV vectors that encoded Gαq-DREADDs under the control of the gfap promotor to specifically stimulate astrocytes in the SDH. A previous study that used the same AAV vector showed that a bath application of CNO increased [Ca 2+ ] i in primary astrocytes (Bull et al., 2014) . Astrocytes respond to several transmitters through Gαq-protein coupled receptors, which increase [Ca 2+ ] i (Sherwood et al., 2017 ). An increase in [Ca 2+ ] i is both necessary and sufficient for most forms of astrocytic transmitter release (Parpura et al., 1994 response in astrocytes and stimulates L-lactate production and release (Tang et al., 2014) . This study confirmed that extracellular L-lactate was increased after the selective activation of Gq-signaling in SDH astrocytes. These results suggested that increased [Ca 2+ ] i in astrocytes evokes the release of glutamate and L-lactate. L-lactate reportedly stimulates the expression of synaptic plasticity-related genes, such as Arc, c-Fos, and EGR1, in a NMDA receptor activationdependent manner (Yang et al., 2014) . Therefore, the selective stimulation of astrocytes might have increased the production and release of L-lactate, which then activated the glutamatergic systems. This suggestion supports our conclusion that SDH astrocyte-selective DREADD stimulation caused mechanical hypersensitivity through the increased release of L-lactate.
In addition, we examined the effects of the intrathecal treatment Previous studies have indicated that the activation of dorsal horn microglia or astrocytes is sufficient to cause pain sensitization in neuropathic pain (Raghavendra et al., 2003; Tsuda et al., 2003) . Excessive synaptic accumulation of various neuroactive substances that are released from activated astrocytes is thought to be associated with neuronal hyperactivity, which is an important element in persistent pain states (DeLeo & Yezierski, 2001) . In this study, we observed that the acute inhibition of astrocytes or L-lactate in the spinal cord attenuated the mechanical hyperalgesia observed in nerve-ligated mice. To the best of our knowledge, these results are the first indication that acute astroglial manipulation ameliorates the mechanical hyperalgesia in neuropathic pain. Therefore, it can be hypothesized that neuro- Additional studies are needed to clarify this possibility.
Treatment with L-lactate induced the phosphorylation of cofilin, which is involved in long-term synaptic plasticity (Suzuki et al., 2011) .
We observed that L-lactate treatment increased the phosphorylation of cofilin in the spinal cord ( Figure 5 ). These L-lactate-induced changes were inhibited by treatment with the MCT inhibitor 4-CIN. Cofilin is inactivated by phosphorylation, which reduces its binding to actin filaments, thus promoting actin polymerization and filament loading (Niwa, Nagata-Ohashi, Takeichi, Mizuno, & Uemura, 2002; Thirone et al., 2009) . Importantly, prolonged cofilin activation may negatively affect the levels of cell surface AMPA receptor in the spine (Gu et al., 2010) , and these receptors are known to be involved in neuropathic pain (Galan, Laird, & Cervero, 2004) . Therefore, L-lactate-induced cofilin phosphorylation may also be involved in spinal nociceptive sensitization.
In this study, we demonstrated that the hyperalgesia in neuropathic pain was maintained by L-lactate overload resulting from aberrant spinal ANLS. Moreover, spinal astrocytes induced nociceptive hypersensitivity by themselves through excessive L-lactate release.
The normalization of ANLS might be an attractive new target for the treatment of neuropathic pain.
